Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 6,587

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary

PAUWELS, ROMAIN A., BUIST, A. SONIA, CALVERLEY, PETER M. A., JENKINS, CHRISTINE R., HURD, SUZANNE S.·2001·American Journal of Respiratory and Critical Care Medicine
DOI 10.1164/ajrccm.163.5.2101039
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/ajrccm.163.5.2101039

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 170

  1. Murray, 1996, Evidence-based health policy—lessons from the Global Burden of Disease Study., Science, 274, 740, 10.1126/science.274.5288.740 · DOI · Paper page
  2. Hill, 1999, The interrelationship of sputum inflammatory markers in patients with chronic bronchitis., Am J Respir Crit Care Med, 160, 893, 10.1164/ajrccm.160.3.9901091 · DOI · Paper page
  3. Keatings, 1996, Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma., Am J Respir Crit Care Med, 153, 530, 10.1164/ajrccm.153.2.8564092 · DOI · Paper page
  4. Pesci, 1998, Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease., Eur Respir J, 12, 380, 10.1183/09031936.98.12020380 · DOI · Paper page
  5. Yamamoto, 1997, Airway inflammation in COPD assessed by sputum levels of interleukin-8., Chest, 112, 505, 10.1378/chest.112.2.505 · DOI · Paper page
  6. Mueller, 1996, Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis., Respir Med, 90, 79, 10.1016/S0954-6111(96)90202-4 · DOI
  7. Mullen, 1985, Reassessment of inflammation of airways in chronic bronchitis., Br Med J (Clin Res Ed), 291, 1235, 10.1136/bmj.291.6504.1235 · DOI · Paper page
  8. Cosio, 1978, The relations between structural changes in small airways and pulmonary-function tests., N Engl J Med, 298, 1277, 10.1056/NEJM197806082982303 · DOI · Paper page
  9. Niewoehner, 1974, Pathologic changes in the peripheral airways of young cigarette smokers., N Engl J Med, 291, 755, 10.1056/NEJM197410102911503 · DOI · Paper page
  10. Wright, 1983, Morphology of peripheral airways in current smokers and ex-smokers., Am Rev Respir Dis, 127, 474, 10.1164/arrd.1983.127.4.474 · DOI · Paper page
  11. Ollerenshaw, 1992, Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation., Am Rev Respir Dis, 145, 922, 10.1164/ajrccm/145.4_Pt_1.922 · DOI · Paper page
  12. Hunninghake, 1983, Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers., Am Rev Respir Dis, 128, 833
  13. Li, 1999, Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats., Inhal Toxicol, 11, 709, 10.1080/089583799196826 · DOI · Paper page
  14. Monn, 1999, Cytotoxicity and induction of proinflammatory cytokines from human monocytes exposed to fine (PM2.5) and coarse particles (PM10–2.5) in outdoor and indoor air., Toxicol Appl Pharmacol, 155, 245, 10.1006/taap.1998.8591 · DOI · Paper page
  15. Salvi, 1999, Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers., Am J Respir Crit Care Med, 159, 702, 10.1164/ajrccm.159.3.9709083 · DOI · Paper page
  16. Von Essen, 1995, Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge., Chest, 108, 1425, 10.1378/chest.108.5.1425 · DOI
  17. Von Essen, 1988, Mechanisms of neutrophil recruitment to the lung by grain dust exposure [published erratum appears in Am Rev Respir Dis 1989;139:1065]., Am Rev Respir Dis, 138, 921, 10.1164/ajrccm/138.4.921 · DOI
  18. O'Shaughnessy, 1997, Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1., Am J Respir Crit Care Med, 155, 852, 10.1164/ajrccm.155.3.9117016 · DOI · Paper page
  19. Saetta, 1993, Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis., Am Rev Respir Dis, 147, 301, 10.1164/ajrccm/147.2.301 · DOI · Paper page
  20. Saetta, 1998, CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease., Am J Respir Crit Care Med, 157, 822, 10.1164/ajrccm.157.3.9709027 · DOI · Paper page
  21. Leopold, 1957, Centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis., Thorax, 12, 219, 10.1136/thx.12.3.219 · DOI · Paper page
  22. McLean, 1958, Pathogenesis of pulmonary emphysema., Am J Med, 25, 62, 10.1016/0002-9343(58)90199-2 · doi:10.1016/0002-9343(58)90199-2
  23. Repine, 1997, Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group., Am J Respir Crit Care Med, 156, 341, 10.1164/ajrccm.156.2.9611013 · DOI · Paper page
  24. Wright, 1983, The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease: the effect of oxygen and exercise., Am Rev Respir Dis, 128, 702
  25. Peinado, 1999, Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease., Am J Respir Crit Care Med, 159, 1605, 10.1164/ajrccm.159.5.9807059 · DOI · Paper page
  26. MacNee, 1994, Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part Two., Am J Respir Crit Care Med, 150, 1158, 10.1164/ajrccm.150.4.7921453 · DOI
  27. Pride, 1989, Diagnostic labels applied to model case histories of chronic airflow obstruction: responses to a questionnaire in 11 North American and western European countries., Eur Respir J, 2, 702, 10.1183/09031936.93.02080702 · DOI
  28. Mannino, 1997, Obstructive lung disease deaths in the United States from 1979 through 1993: an analysis using multiple-cause mortality data., Am J Respir Crit Care Med, 156, 814, 10.1164/ajrccm.156.3.9702026 · DOI · Paper page
  29. Thom, 1989, International comparisons in COPD mortality., Am Rev Respir Dis, 140, S27, 10.1164/ajrccm/140.3_Pt_2.S27 · DOI
  30. Xu, 1994, Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences., Eur Respir J, 7, 1056, 10.1183/09031936.94.07061056 · DOI · Paper page
  31. Feinleib, 1989, Trends in COPD morbidity and mortality in the United States., Am Rev Respir Dis, 140, S9, 10.1164/ajrccm/140.3_Pt_2.S9 · DOI · Paper page
  32. Anthonisen, 1994, Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study., JAMA, 272, 1497, 10.1001/jama.1994.03520190043033 · DOI · Paper page
  33. Laurell, 1963, The electrophoretic alpha-1 globulin pattern of serum in alpha-1 antitrypsin deficiency., Scand J Clin Lab Invest, 15, 132
  34. Hagstrom, 1998, Asthma in adult life—is there an association with birth weight?, Scand J Prim Health Care, 16, 117, 10.1080/028134398750003287 · DOI
  35. Svanes, 1998, Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway., Eur Respir J, 12, 1366, 10.1183/09031936.98.12061366 · DOI
  36. Todisco, 1993, Mild prematurity and respiratory functions., Eur J Pediatr, 152, 55, 10.1007/BF02072517 · DOI
  37. Stein, 1997, Relation of fetal growth to adult lung function in South India., Thorax, 52, 895, 10.1136/thx.52.10.895 · DOI · Paper page
  38. Morgan, 1998, Maternal smoking and infant lung function: further evidence for an in utero effect., Am J Respir Crit Care Med, 158, 689, 10.1164/ajrccm.158.3.ed07-98 · DOI
  39. Tager, 1988, The natural history of forced expiratory volumes: effect of cigarette smoking and respiratory symptoms., Am Rev Respir Dis, 138, 837, 10.1164/ajrccm/138.4.837 · DOI · Paper page
  40. Leuenberger, 1994, Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team., Am J Respir Crit Care Med, 150, 1222, 10.1164/ajrccm.150.5.7952544 · DOI · Paper page
  41. Dayal, 1994, Passive smoking in obstructive respiratory disease in an industrialized urban population., Environ Res, 65, 161, 10.1006/enrs.1994.1029 · DOI
  42. Holt, 1987, Immune and inflammatory function in cigarette smokers., Thorax, 42, 241, 10.1136/thx.42.4.241 · DOI · Paper page
  43. Kauffmann, 1979, Twelve years spirometric changes among Paris area workers., Int J Epidemiol, 8, 201, 10.1093/ije/8.3.201 · DOI
  44. Chen, 1999, Worldwide epidemiology of chronic obstructive pulmonary disease., Current Opin Pulmon Med, 5, 93, 10.1097/00063198-199903000-00003 · DOI
  45. Perez-Padilla, 1996, Exposure to biomass smoke and chronic airway disease in Mexican women., Am J Respir Crit Care Med, 154, 701, 10.1164/ajrccm.154.3.8810608 · DOI · Paper page
  46. Behera, 1991, Respiratory symptoms in Indian women using domestic cooking fuels., Chest, 100, 385, 10.1378/chest.100.2.385 · DOI · Paper page
  47. Amoli, 1998, Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke., Eur Respir J, 11, 659, 10.1183/09031936.98.11030659 · DOI
  48. Dennis, 1996, Woodsmoke exposure and risk for obstructive airways disease among women., Chest, 109, 115, 10.1378/chest.109.1.115 · DOI · Paper page
  49. Pandey, 1984, Prevalence of chronic bronchitis in a rural community of the Hill Region of Nepal., Thorax, 39, 331, 10.1136/thx.39.5.331 · DOI
  50. Pandey, 1984, Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal., Thorax, 39, 337, 10.1136/thx.39.5.337 · DOI · Paper page
  51. Samet, 1987, Health effects and sources of indoor air pollution., Am Rev Respir Dis, 136, 1486, 10.1164/ajrccm/136.6.1486 · DOI · Paper page
  52. Tao, 1992, Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai., Sci Total Environ, 127, 57, 10.1016/0048-9697(92)90469-9 · DOI
  53. Prescott, 1999, Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study., Eur Respir J, 13, 1109, 10.1034/j.1399-3003.1999.13e28.x · DOI · Paper page
  54. Loveridge, 1986, Alteration in breathing pattern with progression of chronic obstructive pulmonary disease., Am Rev Respir Dis, 134, 930, 10.1164/arrd.1986.134.5.930 · DOI
  55. Kesten, 1993, Physician perceptions and management of COPD., Chest, 104, 254, 10.1378/chest.104.1.254 · DOI
  56. Wilson, 1990, “Sick of Smoking”: evaluation of a targeted minimal smoking cessation intervention in general practice., Med J Aust, 152, 518, 10.5694/j.1326-5377.1990.tb125351.x · DOI
  57. Britton, 1999, Helping people to stop smoking: the new smoking cessation guidelines., Thorax, 54, 1, 10.1136/thx.54.1.1 · DOI
  58. Glynn, 1990, Physician-initiated smoking cessation program: the National Cancer Institute trials., Prog Clin Biol Res, 339, 11
  59. Fiore, 1994, The effectiveness of the nicotine patch for smoking cessation: a meta-analysis., JAMA, 271, 1940, 10.1001/jama.1994.03510480064036 · DOI · Paper page
  60. Lancaster, 2000, Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library., BMJ, 321, 355, 10.1136/bmj.321.7257.355 · DOI · Paper page
  61. Ries, 1995, Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease., Ann Intern Med, 122, 823, 10.7326/0003-4819-122-11-199506010-00003 · DOI · Paper page
  62. Janelli, 1991, Can a pulmonary health teaching program alter patients' ability to cope with COPD?, Rehabil Nurs, 16, 199, 10.1002/j.2048-7940.1991.tb01213.x · DOI
  63. Ashikaga, 1980, Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease., J Rehabil, 46, 23
  64. Toshima, 1990, Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status., Health Psychol, 9, 237, 10.1037/0278-6133.9.3.237 · DOI
  65. Celli, 1995, Pulmonary rehabilitation in patients with COPD., Am J Respir Crit Care Med, 152, 861, 10.1164/ajrccm.152.3.7663796 · DOI · Paper page
  66. Heffner, 1997, Outcomes of advance directive education of pulmonary rehabilitation patients., Am J Respir Crit Care Med, 155, 1055, 10.1164/ajrccm.155.3.9116986 · DOI
  67. Stewart, 1995, Effective physician–patient communication and health outcomes: a review., CMAJ, 152, 1423
  68. Clark, 1995, Physician–patient partnership in managing chronic illness., Acad Med, 70, 957, 10.1097/00001888-199511000-00008 · DOI
  69. Pauwels, 1999, Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease., N Engl J Med, 340, 1948, 10.1056/NEJM199906243402503 · DOI · Paper page
  70. Vestbo, 1999, Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial., Lancet, 353, 1819, 10.1016/S0140-6736(98)10019-3 · DOI · Paper page
  71. Burge, 2000, Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial., BMJ, 320, 1297, 10.1136/bmj.320.7245.1297 · DOI · Paper page
  72. Vathenen, 1988, High-dose inhaled albuterol in severe chronic airflow limitation., Am Rev Respir Dis, 138, 850, 10.1164/ajrccm/138.4.850 · DOI
  73. Gross, 1989, Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease: A three-center study., Am Rev Respir Dis, 139, 1188, 10.1164/ajrccm/139.5.1188 · DOI
  74. Chrystyn, 1988, Dose response relation to oral theophylline in severe chronic obstructive airways disease., BMJ, 297, 1506, 10.1136/bmj.297.6662.1506 · DOI · Paper page
  75. Higgins, 1991, Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis., Eur Respir J, 4, 415, 10.1183/09031936.93.04040415 · DOI
  76. Jenkins, 1987, Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation., Chest, 91, 804, 10.1378/chest.91.6.804 · DOI
  77. Ikeda, 1996, Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease., Thorax, 51, 48, 10.1136/thx.51.1.48 · DOI
  78. Guyatt, 1987, Bronchodilators in chronic air-flow limitation: effects on airway function, exercise capacity, and quality of life., Am Rev Respir Dis, 135, 1069
  79. Jones, 1997, Quality of life changes in COPD patients treated with salmeterol., Am J Respir Crit Care Med, 155, 1283, 10.1164/ajrccm.155.4.9105068 · DOI · Paper page
  80. Mahler, 1999, Efficacy of salmeterol xinafoate in the treatment of COPD., Chest, 115, 957, 10.1378/chest.115.4.957 · DOI · Paper page
  81. Gross, 1998, Inhalation by nebulization of albuterol–ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group., Respiration, 65, 354, 10.1159/000029295 · DOI
  82. Ulrik, 1995, Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study., Thorax, 50, 750, 10.1136/thx.50.7.750 · DOI
  83. Taylor, 1985, The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction., Am Rev Respir Dis, 131, 747
  84. van Noord, 2000, Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium., Eur Respir J, 15, 878, 10.1034/j.1399-3003.2000.15e11.x · DOI · Paper page
  85. Murciano, 1989, A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease., N Engl J Med, 320, 1521, 10.1056/NEJM198906083202304 · DOI · Paper page
  86. O'Driscoll, 1992, A long-term prospective assessment of home nebulizer treatment., Respir Med, 86, 317, 10.1016/S0954-6111(06)80031-4 · DOI
  87. Tashkin, 1996, Results of a multicenter study of nebulized inhalant bronchodilator solutions., Am J Med, 100, 62S, 10.1016/S0002-9343(96)80109-4 · DOI
  88. Senderovitz, 1999, Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine., Respir Med, 93, 715, 10.1016/S0954-6111(99)90038-0 · DOI
  89. Rice, 2000, Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial., Am J Respir Crit Care Med, 162, 174, 10.1164/ajrccm.162.1.9909066 · DOI
  90. Decramer, 1994, Corticosteroids contribute to muscle weakness in chronic airflow obstruction., Am J Respir Crit Care Med, 150, 11, 10.1164/ajrccm.150.1.8025735 · DOI · Paper page
  91. Decramer, 1992, Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma., Am Rev Respir Dis, 146, 800, 10.1164/ajrccm/146.3.800 · DOI
  92. Nichol, 1994, The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community., N Engl J Med, 331, 778, 10.1056/NEJM199409223311206 · DOI · Paper page
  93. Edwards, 1994, A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease., J Infect Dis, 169, 68, 10.1093/infdis/169.1.68 · DOI · Paper page
  94. Simberkoff, 1986, Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration Cooperative Study., N Engl J Med, 315, 1318, 10.1056/NEJM198611203152104 · DOI · Paper page
  95. Williams, 1986, Pneumococcal vaccine and patients with chronic lung disease., Ann Intern Med, 104, 106, 10.7326/0003-4819-104-1-106 · DOI
  96. Davis, 1987, Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease: a pilot study., Chest, 92, 204, 10.1378/chest.92.2.204 · DOI
  97. Siafakas, 1995, Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force., Eur Respir J, 8, 1398, 10.1183/09031936.95.08081398 · DOI · Paper page
  98. Hansen, 1994, Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis., Respir Med, 88, 531, 10.1016/S0954-6111(05)80337-3 · DOI
  99. Boman, 1983, Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases., Eur J Respir Dis, 64, 405
  100. Rasmussen, 1988, Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis., Eur Respir J, 1, 351, 10.1183/09031936.93.01040351 · DOI
  101. Collet, 1997, Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant., Am J Respir Crit Care Med, 156, 1719, 10.1164/ajrccm.156.6.9612096 · DOI · Paper page
  102. Anthonisen, 1997, OM-8BV for COPD., Am J Respir Crit Care Med, 156, 1713, 10.1164/ajrccm.156.6.ed15-97 · DOI
  103. Irwin, 1998, Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians., Chest, 114, 133S, 10.1378/chest.114.2_Supplement.133S · DOI · Paper page
  104. Barbera, 1996, Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease., Lancet, 347, 436, 10.1016/S0140-6736(96)90011-2 · DOI · Paper page
  105. Bardsley, 1991, Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease., Eur Respir J, 4, 308, 10.1183/09031936.93.04030308 · DOI
  106. Watanabe, 1989, Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease., Am Rev Respir Dis, 140, 1269, 10.1164/ajrccm/140.5.1269 · DOI
  107. Winkelmann, 1994, Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease., Chest, 105, 1383, 10.1378/chest.105.5.1383 · DOI
  108. Eiser, 1991, Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the “pink puffer” syndrome., Eur Respir J, 4, 926, 10.1183/09031936.93.04080926 · DOI
  109. Young, 1989, Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease., Thorax, 44, 387, 10.1136/thx.44.5.387 · DOI
  110. Rice, 1987, Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction., Br J Dis Chest, 81, 287, 10.1016/0007-0971(87)90163-X · DOI
  111. Woodcock, 1981, Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases., N Engl J Med, 305, 1611, 10.1056/NEJM198112313052703 · DOI · Paper page
  112. Poole, 1998, The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease., Am J Respir Crit Care Med, 157, 1877, 10.1164/ajrccm.157.6.9711061 · DOI
  113. Berry, 1999, Exercise rehabilitation and chronic obstructive pulmonary disease stage., Am J Respir Crit Care Med, 160, 1248, 10.1164/ajrccm.160.4.9901014 · DOI · Paper page
  114. Foglio, 1999, Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction., Eur Respir J, 13, 125, 10.1183/09031936.99.13112599 · DOI · Paper page
  115. Young, 1999, Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme., Aust N Z J Med, 29, 59, 10.1111/j.1445-5994.1999.tb01589.x · DOI
  116. Wijkstra, 1994, Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home., Eur Respir J, 7, 269, 10.1183/09031936.94.07020269 · DOI · Paper page
  117. McGavin, 1977, Physical rehabilitation for the chronic bronchitic: results of a controlled trial of exercises in the home., Thorax, 32, 307, 10.1136/thx.32.3.307 · DOI · Paper page
  118. Tarpy, 1995, Long-term oxygen therapy., N Engl J Med, 333, 710, 10.1056/NEJM199509143331107 · DOI · Paper page
  119. Mehran, 1995, Indications for surgery and patient work-up for bullectomy., Chest Surg Clin North Am, 5, 717, 10.1016/S1052-3359(25)00735-5 · DOI
  120. Benditt, 1997, Surgical options for patients with advanced emphysema., Clin Chest Med, 18, 577, 10.1016/S0272-5231(05)70403-2 · DOI
  121. Geddes, 2000, Effect of lung-volume-reduction surgery in patients with severe emphysema., N Engl J Med, 343, 239, 10.1056/NEJM200007273430402 · DOI · Paper page
  122. Trulock, 1997, Lung transplantation., Am J Respir Crit Care Med, 155, 789, 10.1164/ajrccm.155.3.9117010 · DOI · Paper page
  123. Theodore, 1990, Lung transplantation comes of age., N Engl J Med, 322, 772, 10.1056/NEJM199003153221110 · DOI
  124. Hosenpud, 1998, The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report—1998., J Heart Lung Transplant, 17, 656
  125. Maurer, 1998, International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society., Transplantation, 66, 951, 10.1097/00007890-199810150-00033 · DOI · Paper page
  126. Regueiro, 1998, A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment., Am J Med, 10, 366, 10.1016/S0002-9343(98)00290-3 · DOI
  127. Gibson, 1998, Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital., J Qual Clin Pract, 18, 125
  128. Warren, 1980, Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961–68 and 1970–76., Lancet, 1, 467, 10.1016/S0140-6736(80)91008-9 · DOI
  129. Anthonisen, 1987, Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease., Ann Intern Med, 106, 196, 10.7326/0003-4819-106-2-196 · DOI · Paper page
  130. Wilson, 1998, The role of infection in COPD., Chest, 113, 242S, 10.1378/chest.113.4_Supplement.242S · DOI
  131. Soler, 1998, Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation., Am J Respir Crit Care Med, 157, 1498, 10.1164/ajrccm.157.5.9711044 · DOI · Paper page
  132. Smith, 1980, Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases., J Infect Dis, 141, 271, 10.1093/infdis/141.3.271 · DOI
  133. MacFarlane, 1993, Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community., Lancet, 341, 511, 10.1016/0140-6736(93)90275-L · DOI · Paper page
  134. Stockley, 2000, Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD., Chest, 117, 1638, 10.1378/chest.117.6.1638 · DOI · Paper page
  135. Anderson, 1997, Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project., Eur Respir J, 10, 1064, 10.1183/09031936.97.10051064 · DOI · Paper page
  136. Chodosh, 1998, Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group., Clin Infect Dis, 27, 722, 10.1086/514930 · DOI
  137. Mogulkoc, 1999, Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection., Am J Respir Crit Care Med, 160, 349, 10.1164/ajrccm.160.1.9809041 · DOI
  138. Murphy, 1999, Simultaneous respiratory tract colonization by multiple strains of nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy., J Infect Dis, 180, 404, 10.1086/314870 · DOI
  139. Emerman, 1991, Spirometric criteria for hospital admission of patients with acute exacerbation of COPD., Chest, 99, 595, 10.1378/chest.99.3.595 · DOI
  140. Emerman, 1994, Physician estimation of FEV1 in acute exacerbation of COPD., Chest, 105, 1709, 10.1378/chest.105.6.1709 · DOI
  141. Emerman, 1996, Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease., Ann Emerg Med, 27, 159, 10.1016/S0196-0644(96)70317-7 · DOI
  142. Emerman, 1989, Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease., Ann Emerg Med, 18, 523, 10.1016/S0196-0644(89)80837-6 · DOI
  143. Thompson, 1996, Controlled trial of oral prednisone in outpatients with acute COPD exacerbation., Am J Respir Crit Care Med, 154, 407, 10.1164/ajrccm.154.2.8756814 · DOI · Paper page
  144. Davies, 1999, Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial., Lancet, 354, 456, 10.1016/S0140-6736(98)11326-0 · DOI · Paper page
  145. Niewoehner, 1999, Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group., N Engl J Med, 340, 1941, 10.1056/NEJM199906243402502 · DOI · Paper page
  146. Connors, 1996, Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators., Am J Respir Crit Care Med, 154, 959, 10.1164/ajrccm.154.4.8887592 · DOI · Paper page
  147. Shepperd, 1998, Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis., BMJ, 316, 1791, 10.1136/bmj.316.7147.1791 · DOI · Paper page
  148. Gravil, 1998, Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service., Lancet, 351, 1853, 10.1016/S0140-6736(97)11048-0 · DOI
  149. Moayyedi, 1995, Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease., Thorax, 50, 834, 10.1136/thx.50.8.834 · DOI
  150. Fernandez, 1994, Comparison of one versus two bronchodilators in ventilated COPD patients., Intensive Care Med, 20, 199, 10.1007/BF01704700 · DOI
  151. Barbera, 1992, Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease., Am Rev Respir Dis, 145, 1328, 10.1164/ajrccm/145.6.1328 · DOI
  152. Mahon, 1999, Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice., Chest, 115, 38, 10.1378/chest.115.1.38 · DOI
  153. Lloberes, 1988, Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease., Eur Respir J, 1, 536, 10.1183/09031936.93.01060536 · DOI
  154. Murciano, 1984, Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease., N Engl J Med, 311, 349, 10.1056/NEJM198408093110601 · DOI · Paper page
  155. Emerman, 1990, Theophylline concentrations in patients with acute exacerbation of COPD., Am J Emerg Med, 8, 289, 10.1016/0735-6757(90)90076-C · DOI
  156. Meyer, 1994, Noninvasive positive pressure ventilation to treat respiratory failure., Ann Intern Med, 120, 760, 10.7326/0003-4819-120-9-199405010-00008 · DOI · Paper page
  157. Bott, 1993, Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease., Lancet, 341, 1555, 10.1016/0140-6736(93)90696-E · DOI · Paper page
  158. Brochard, 1995, Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease., N Engl J Med, 333, 817, 10.1056/NEJM199509283331301 · DOI · Paper page
  159. Kramer, 1995, Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure., Am J Respir Crit Care Med, 151, 1799, 10.1164/ajrccm.151.6.7767523 · DOI · Paper page
  160. Plant, 2000, Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial., Lancet, 355, 1931, 10.1016/S0140-6736(00)02323-0 · DOI · Paper page
  161. Esteban, 2000, How is mechanical ventilation employed in the intensive care unit? An international utilization review., Am J Respir Crit Care Med, 161, 1450, 10.1164/ajrccm.161.5.9902018 · DOI · Paper page
  162. Esteban, 1995, for the Spanish Lung Failure Collaborative Group. A comparison of four methods of weaning patients from mechanical ventilation., N Engl J Med, 332, 345, 10.1056/NEJM199502093320601 · DOI · Paper page
  163. Nava, 1998, Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: a randomized, controlled trial., Ann Intern Med, 128, 721, 10.7326/0003-4819-128-9-199805010-00004 · DOI · Paper page
  164. Hilbert, 1998, Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency., Eur Respir J, 11, 1349, 10.1183/09031936.98.11061349 · DOI · Paper page
  165. Kessler, 1999, Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease., Am J Respir Crit Care Med, 159, 158, 10.1164/ajrccm.159.1.9803117 · DOI · Paper page
  166. Mushlin, 1991, The necessary length of hospital stay for chronic pulmonary disease., JAMA, 266, 80, 10.1001/jama.1991.03470010084035 · DOI
  167. Stoller, 1998, Inpatient management of chronic obstructive pulmonary disease., Respir Care Clin North Am, 4, 425
  168. Peach, 1981, Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis., Thorax, 36, 585, 10.1136/thx.36.8.585 · DOI
  169. Rutten-van Mölken, 1999, Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands., Respir Med, 93, 779, 10.1016/S0954-6111(99)90262-7 · DOI
  170. Jacobson, 2000, The economic impact of asthma and COPD in Sweden 1980 and 1991., Respir Med, 94, 247, 10.1053/rmed.1999.0733 · DOI

Cited by

See all 6,587

Metadata

Authors
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S.
Venue
American Journal of Respiratory and Critical Care Medicine
Publisher
Oxford University Press (OUP)
Published
2001-04-01
Volume
163
Issue
5
Pages
1256-1276
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
DOI
10.1164/ajrccm.163.5.2101039
OpenAlex
W2045616259
Cited by
6,587
References
3
FWCI
221.15
Type
journal article
Language
en
Open access
closed
Licence
academic.oup.com/pages/standard-publication-reuse-rights (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. https://app.cochat.ai/papers/10.1164/ajrccm.163.5.2101039
The paper
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.163.5.2101039

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.